Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Earnings Calendar - May 14, 2024
Showing earnings announcements on May 14, 2024
Name | Company | Market Cap | EPS (Forecast) | EPS (Actual) | Revenue (Forecast) | Revenue (Actual) | Time | Analyst Consensus | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
 | Alibaba | $205.29B | $1.44 | $30.90B | xxxxxxxxxxxxx | |||||
 | Home Depot | $391.11B | $3.60 | $36.63B | xxxxxxxxxxxxx | |||||
 | Tencent Holdings | $478.66B | $0.62 | $21.89B | xxxxxxxxxxxxx | |||||
 | Sea | $54.02B | $0.23 | $3.64B | xxxxxxxxxxxxx | |||||
 | Ocugen | $262.24M | ― | ― | ― | xxxxxxxxxxxxx | ||||
 | Sony Group | $111.04B | $0.14 | $19.06B | ― | xxxxxxxxxxxxx | ||||
 | Canoo | $65.75M | ― | ― | ― | ― | xxxxxxxxxxxxx | |||
 | Nu Holdings | $72.13B | $0.08 | $2.16B | xxxxxxxxxxxxx | |||||
 | Vodafone | $24.22B | $0.54 | $23.60B | xxxxxxxxxxxxx | |||||
 | Mullen Automotive | $11.40M | ― | ― | ― | xxxxxxxxxxxxx | ||||
 | Jaguar Animal Health | $9.70M | ― | ― | ― | ― | xxxxxxxxxxxxx | |||
 | Oxford Lane Capital | ― | $0.34 | $84.80M | xxxxxxxxxxxxx | |||||
 | Intuitive Machines | $1.00B | $0.07 | $55.90M | xxxxxxxxxxxxx | |||||
 | 9 Meters Biopharma | $14.00 | ― | ― | ― | ― | ― | xxxxxxxxxxxxx | ||
 | Bayer | $26.50B | $0.62 | $15.20B | xxxxxxxxxxxxx | |||||
 | Talphera | $15.95M | -$0.25 | $0.00 | xxxxxxxxxxxxx | |||||
 | American Battery Technology | $71.81M | -$0.13 | $250.00K | ― | xxxxxxxxxxxxx | ||||
 | Daré Bioscience | $36.15M | -$0.72 | $260.00K | xxxxxxxxxxxxx | |||||
 | Citius Pharmaceuticals | $67.36M | -$0.06 | $0.00 | xxxxxxxxxxxxx | |||||
 | DHT Holdings | $1.67B | $0.30 | $106.81M | xxxxxxxxxxxxx | |||||
 | Sunworks | $57.00 | ― | ― | ― | ― | ― | xxxxxxxxxxxxx | ||
 | Kala Pharmaceuticals | $32.44M | -$2.89 | $0.00 | xxxxxxxxxxxxx | |||||
 | On Holding AG | $15.18B | $0.16 | $573.39M | xxxxxxxxxxxxx | |||||
 | Ovid Therapeutics | $80.20M | -$0.22 | $52.00K | xxxxxxxxxxxxx | |||||
 | Cellectar Biosciences | $82.76M | -$0.49 | $0.00 | xxxxxxxxxxxxx | |||||
 | Energous | $3.91M | -$0.81 | $146.00K | xxxxxxxxxxxxx | |||||
 | Capital Southwest | $1.15B | $0.66 | $45.64M | xxxxxxxxxxxxx | |||||
 | Rockwell Med | $113.26M | -$0.04 | $21.70M | xxxxxxxxxxxxx | |||||
 | Kopin | $123.78M | -$0.05 | $9.01M | xxxxxxxxxxxxx | |||||
 | Syros Pharmaceuticals | $67.56M | -$0.85 | $720.00K | xxxxxxxxxxxxx | |||||
 | Eos Energy Enterprises | $673.96M | -$0.23 | $6.77M | xxxxxxxxxxxxx | |||||
 | Precigen | $226.78M | -$0.09 | $1.48M | xxxxxxxxxxxxx | |||||
 | Infinera | $1.58B | $0.12 | $453.46M | xxxxxxxxxxxxx | |||||
 | SELLAS Life Sciences Group | $75.91M | -$0.16 | ― | xxxxxxxxxxxxx | |||||
 | SFL Corporation | $1.55B | $0.27 | $212.86M | xxxxxxxxxxxxx | |||||
 | Taysha Gene Therapies | $346.35M | -$0.11 | $2.88M | xxxxxxxxxxxxx | |||||
 | Rumble | $2.27B | -$0.19 | $18.27M | xxxxxxxxxxxxx | |||||
 | Ontrak | $7.63M | ― | ― | ― | ― | xxxxxxxxxxxxx | |||
 | TuHURA Biosciences | $239.15M | -$8.75 | ― | xxxxxxxxxxxxx | |||||
 | Verb Technology Company | $8.28M | -$0.02 | $0.00 | ― | xxxxxxxxxxxxx | ||||
 | Lightning eMotors | $1.32K | ― | ― | ― | ― | ― | xxxxxxxxxxxxx | ||
 | DermTech | $3.52K | -$0.57 | $3.94M | xxxxxxxxxxxxx | |||||
 | ENDRA Life Sciences | $4.56M | -$13.50 | $0.00 | xxxxxxxxxxxxx | |||||
 | Arcutis Biotherapeutics | $971.36M | -$0.69 | $15.18M | xxxxxxxxxxxxx | |||||
 | International Game Technology | $4.10B | $0.31 | $1.03B | xxxxxxxxxxxxx | |||||
 | Unity Biotechnology | $22.91M | ― | ― | ― | ― | xxxxxxxxxxxxx | |||
 | TRACON Pharmaceuticals | $187.42K | -$1.19 | $0.00 | xxxxxxxxxxxxx | |||||
 | InspireMD | $63.75M | -$0.18 | $2.00M | xxxxxxxxxxxxx | |||||
 | Cyclacel Pharmaceuticals | $1.40M | -$4.75 | $0.00 | xxxxxxxxxxxxx | |||||
 | Delcath Systems | $304.93M | -$0.45 | $2.22M | xxxxxxxxxxxxx | |||||
 | Pixelworks | $40.65M | -$0.08 | $16.00M | xxxxxxxxxxxxx | |||||
 | CareCloud | $37.45M | -$0.29 | $26.04M | xxxxxxxxxxxxx | |||||
 | GeoVax Labs | $16.79M | -$5.56 | $0.00 | xxxxxxxxxxxxx | |||||
 | Kyverna Therapeutics, Inc. | $206.24M | -$0.84 | $0.00 | xxxxxxxxxxxxx | |||||
 | Adicet Bio | $105.47M | -$0.45 | $0.00 | xxxxxxxxxxxxx | |||||
 | Tenaya Therapeutics | $151.47M | -$0.42 | $0.00 | xxxxxxxxxxxxx | |||||
 | NEXTracker, Inc. Class A | $5.79B | $0.65 | $683.17M | xxxxxxxxxxxxx | |||||
 | Jasper Therapeutics | $319.93M | -$1.23 | $0.00 | xxxxxxxxxxxxx | |||||
 | Synlogic | $16.84M | -$0.82 | $0.00 | xxxxxxxxxxxxx | |||||
 | AbSci | $436.06M | -$0.21 | $2.10M | xxxxxxxxxxxxx | |||||
 | Boot Barn | $3.80B | $0.89 | $384.89M | xxxxxxxxxxxxx | |||||
 | Origin Materials | $202.59M | -$0.10 | $6.48M | xxxxxxxxxxxxx | |||||
 | Tenax Therapeutics | $14.97M | -$2.40 | $0.00 | xxxxxxxxxxxxx | |||||
 | Brainstorm Cell Therapeutics | $9.94M | ― | ― | ― | ― | xxxxxxxxxxxxx | |||
 | General Cannabis | $5.60M | ― | ― | ― | xxxxxxxxxxxxx | ||||
 | BioAtla | $92.80M | -$0.54 | $0.00 | xxxxxxxxxxxxx | |||||
 | Longeveron | $30.01M | -$2.00 | $60.00K | xxxxxxxxxxxxx | |||||
 | Greenlane Holdings | $1.77M | ― | ― | ― | ― | ― | xxxxxxxxxxxxx | ||
 | CV Sciences | $8.09M | ― | ― | xxxxxxxxxxxxx | |||||
 | Palisade Bio | $3.62M | -$3.75 | ― | xxxxxxxxxxxxx | |||||
 | Poseida Therapeutics | $230.21M | -$0.42 | $11.67M | xxxxxxxxxxxxx | |||||
 | Cemtrex | $6.87M | -$4.20 | $16.39M | xxxxxxxxxxxxx | |||||
 | Tingo Group | $2.56M | ― | ― | ― | ― | ― | xxxxxxxxxxxxx | ||
 | Evoke Pharma | $4.79M | -$2.52 | $2.14M | xxxxxxxxxxxxx | |||||
 | OptimizeRx | $95.64M | ― | ― | ― | ― | xxxxxxxxxxxxx | |||
 | Sonnet BioTherapeutics Holdings | $3.09M | -$5.60 | $12.00K | xxxxxxxxxxxxx | |||||
 | PAVmed | $11.13M | -$1.67 | $1.05M | xxxxxxxxxxxxx | |||||
 | SinglePoint | $4.22K | ― | ― | ― | ― | ― | xxxxxxxxxxxxx | ||
 | Boston Omaha | $464.34M | -$0.05 | $25.50M | xxxxxxxxxxxxx | |||||
 | Optinose | $104.04M | -$0.11 | $14.90M | xxxxxxxxxxxxx | |||||
 | Enveric Biosciences | $4.45M | -$0.78 | $0.00 | ― | xxxxxxxxxxxxx | ||||
 | TFF Pharmaceuticals | $8.67M | -$2.26 | $100.00K | xxxxxxxxxxxxx | |||||
 | Aprea Therapeutics | $21.24M | -$0.76 | $0.00 | xxxxxxxxxxxxx | |||||
 | Passage Bio | $37.99M | -$0.36 | $0.00 | xxxxxxxxxxxxx | |||||
 | Navios Maritime Partners | $1.61B | $2.01 | $283.59M | xxxxxxxxxxxxx | |||||
 | GOL Linhas Aereas Inteligentes SA | $80.35M | $0.07 | $916.38M | xxxxxxxxxxxxx | |||||
 | Ellington Residential Mortgage | $165.64M | $0.25 | $4.37M | xxxxxxxxxxxxx | |||||
 | scPharmaceuticals | $207.62M | -$0.44 | $5.98M | xxxxxxxxxxxxx | |||||
 | Nuvve Holding | $2.42M | ― | ― | xxxxxxxxxxxxx | |||||
 | Jack In The Box | $941.95M | $1.43 | $369.53M | xxxxxxxxxxxxx | |||||
 | Golden Minerals Co | $5.56M | ― | ― | xxxxxxxxxxxxx | |||||
 | Broadwind Energy | $40.01M | -$0.07 | $34.92M | xxxxxxxxxxxxx | |||||
 | Korro Bio | $534.68M | -$2.38 | $0.00 | xxxxxxxxxxxxx | |||||
 | Grifols SA | $6.94B | $0.11 | $1.75B | ― | ― | xxxxxxxxxxxxx | |||
 | Acumen Pharmaceuticals | $173.03M | -$0.26 | ― | xxxxxxxxxxxxx | |||||
 | SeaStar Medical Holding | $13.53M | ― | ― | ― | ― | xxxxxxxxxxxxx | |||
 | DLocal | $2.49B | $0.12 | $189.78M | xxxxxxxxxxxxx | |||||
 | Porsche Automobil Holding | $12.71B | ― | ― | xxxxxxxxxxxxx | |||||
 | Pyxis Oncology | $211.55M | -$0.24 | $4.13M | xxxxxxxxxxxxx | |||||
 | MINISO Group Holding | $6.40B | $0.26 | $514.74M | xxxxxxxxxxxxx |
Rows:
Earnings News
FAQ
When is Earnings Season?
The earnings season usually begins one to two weeks after the end of the last month of each quarter (December, March, June, and September).
How do earnings affect stock prices?
A company's earnings report reveals its profitability and financial stability. If a company’s earnings are reported above expectations, its stock price tends to rise. However, depending on forward guidance and macroeconomic factors, a stock price is still susceptible to volatility.
Is it better to buy a stock before or after earnings?
Stock prices tend to be more volatile before and after a company reports its earnings. Investors should develop an investment thesis using Earnings Reports Insights and other datasets before making any investment decisions.